Adenosine-induced apoptosis in glomerular mesangial cells

Kidney International
Zhihui ZhaoElias A Lianos

Abstract

Mesangial cell apoptosis is a mechanism of resolution of glomerular hypercellularity in inflammatory forms of glomerular injury in which adenosine (ADO) was shown to play an anti-inflammatory role. This, and the observation that mesangial cell have ADO receptors prompted us to determine whether ADO induces mesangial cell apoptosis and to explore underlying mechanisms. Cultured mouse mesangial cell were incubated in the presence or absence of ADO or ADO receptor agonists (R-PIA, NECA, IB-MECA, CGS26180) or antagonists (DPCPX, DPSPX, MRS1191) for 48 hours. Cell death was assessed by trypan blue exclusion analysis. Apoptosis was assessed by DNA fragmentation, TUNEL staining and flow cytometry. ADO and the A3 ADO receptor agonist IB-MECA induced mesangial cell death, which was markedly attenuated by the A3 receptor antagonist MRS1191. The A1 receptor agonist R-PIA, A2 receptor agonist NECA or the A2a receptor agonist CGS-12680 had no effect. The IB-MECA-induced mesangial cell death was due to apoptosis. This occurred via a cAMP independent mechanism. RT-PCR analysis revealed presence of A3, A1 and A2b but lack of A2a receptor transcripts in MC total RNA. Western blot analysis of mesangial cell lysates revealed expression the A3 rec...Continue Reading

References

Jun 1, 1989·Kidney International·A OliveraJ M López-Novoa
Jan 1, 1995·Kidney International·A ShimizuN Yamanaka
Feb 27, 1996·Biochemical and Biophysical Research Communications·Y KohnoK A Jacobson
Jan 1, 1996·Kidney International·H SugiyamaA Ota
Jan 1, 1997·Cellular Signalling·M MacLaughlinJ M Lopez-Novoa
Mar 17, 1997·Biochemical and Biophysical Research Communications·Y YaoK A Jacobson
Nov 19, 1997·Neuropharmacology·T M Palmer, G L Stiles
Mar 10, 2001·Obstetrics and Gynecology·Y YoneyamaT Araki
Aug 21, 2001·Obstetrics and Gynecology·S Matsubara, I Sato

❮ Previous
Next ❯

Citations

Feb 8, 2007·Pflügers Archiv : European journal of physiology·Olivier M NiemoellerFlorian Lang
Jul 20, 2007·Molecular and Cellular Biochemistry·Carlos Martínez-SalgadoJosé M López-Novoa
Apr 1, 2009·Purinergic Signalling·David G ShirleyJean Sévigny
Dec 7, 2011·Purinergic Signalling·Talita GlaserHenning Ulrich
May 19, 2004·The International Journal of Biochemistry & Cell Biology·Mojtaba Panjehpour, Fatemeh Karami-Tehrani
Nov 25, 2003·Kidney International·Qiuling FanYasuhiko Tomino
Jul 29, 2008·Current Opinion in Nephrology and Hypertension·Francesca Di Sole
Nov 23, 2013·Purinergic Signalling·Geoffrey BurnstockMatthew A Bailey
Nov 14, 2006·Experimental Cell Research·Marina HermesDoris Kloor
May 29, 2004·Trends in Pharmacological Sciences·Doris Kloor, Hartmut Osswald
Oct 29, 2005·Biochemical Pharmacology·Kusum K KharbandaDean J Tuma
Jan 23, 2017·Molecular Aspects of Medicine·Carlos OyarzúnRody San Martín
May 27, 2003·The Journal of Pharmacology and Experimental Therapeutics·Zoltán H NémethGyorgy Hasko
Aug 16, 2003·Current Opinion in Nephrology and Hypertension·Paul S Modlinger, William J Welch
Jan 30, 2004·American Journal of Physiology. Renal Physiology·Peter KomlosiPhillip Darwin Bell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis